Relative Frequency and Distinctive Features of Anti-Ma2 Nonparaneoplastic Neurologic Disorders
Patients with I-Ma2 are more common than anticipated and have insidious disease onset and a tendency for monofocal nervous system involvement. Recognition of patients with I-Ma2 is delayed and must be improved.
Authors
- Antonio Farina (ORCID: https://orcid.org/0000-0002-5551-0185)
- Louis Comperat (ORCID: https://orcid.org/0000-0002-4279-1256)
- Maxime Bonjour (ORCID: https://orcid.org/0000-0003-2205-9655)
- G. Lafuente-Gómez
- Géraldine Picard (ORCID: https://orcid.org/0000-0003-1282-267X)
- Dimitri Psimaras (ORCID: https://orcid.org/0000-0002-6641-288X)
- Nicolás Lundahl Ciano-Petersen (ORCID: https://orcid.org/0000-0001-9555-4847)
- Mantas Vaišvilas (ORCID: https://orcid.org/0000-0002-9306-610X)
- Macarena Villagrán‐García (ORCID: https://orcid.org/0000-0001-9236-2428)
- Bastien Joubert (ORCID: https://orcid.org/0000-0003-4631-3056)
- Jerome Honnorat
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Vilnius University (LT)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hospices Civils de Lyon (FR)
- Pitié-Salpêtrière Hospital (FR)
- Laboratoire de Biométrie et Biologie Evolutive (FR)
- Institut du Cerveau (FR)
- Instituto de Investigación Biomédica de Málaga (ES)
Publication Details
- Journal
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1212/nxi.0000000000200538
- Citations
- 1
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 39.15
Funders
- Hospices Civils de Lyon